 Shaodong Dai
Concepts (312)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell | 9 | 2022 | 635 | 2.380 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2022 | 977 | 1.960 |
Why?
| | Nickel | 4 | 2021 | 53 | 1.920 |
Why?
| | Hypersensitivity | 7 | 2021 | 272 | 1.710 |
Why?
| | Autoantigens | 7 | 2022 | 397 | 1.280 |
Why?
| | Prosthesis Failure | 2 | 2021 | 118 | 1.260 |
Why?
| | Peptides | 11 | 2022 | 868 | 1.250 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 310 | 1.190 |
Why?
| | Histocompatibility Antigens Class II | 5 | 2022 | 351 | 1.140 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2022 | 3361 | 1.060 |
Why?
| | Berylliosis | 5 | 2016 | 179 | 1.000 |
Why?
| | Models, Molecular | 23 | 2021 | 1405 | 0.960 |
Why?
| | Haptens | 2 | 2021 | 22 | 0.890 |
Why?
| | T-Lymphocytes | 7 | 2021 | 1769 | 0.860 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 695 | 0.850 |
Why?
| | Insulin | 4 | 2022 | 2135 | 0.840 |
Why?
| | Peptide Fragments | 4 | 2020 | 683 | 0.800 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2022 | 177 | 0.760 |
Why?
| | Joint Prosthesis | 1 | 2021 | 24 | 0.760 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 567 | 0.740 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 176 | 0.740 |
Why?
| | Epitopes | 3 | 2017 | 436 | 0.730 |
Why?
| | Bryostatins | 1 | 2020 | 1 | 0.730 |
Why?
| | Machine Learning | 1 | 2022 | 315 | 0.640 |
Why?
| | Protein Conformation | 13 | 2021 | 833 | 0.640 |
Why?
| | Arthroplasty, Replacement | 2 | 2020 | 47 | 0.610 |
Why?
| | Echinococcus granulosus | 1 | 2017 | 1 | 0.600 |
Why?
| | Organogold Compounds | 1 | 2017 | 5 | 0.600 |
Why?
| | Protein Processing, Post-Translational | 4 | 2018 | 408 | 0.600 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2017 | 14 | 0.600 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 64 | 0.590 |
Why?
| | Transcriptome | 2 | 2020 | 756 | 0.550 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2021 | 170 | 0.540 |
Why?
| | Amino Acid Sequence | 10 | 2019 | 2032 | 0.470 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 223 | 0.460 |
Why?
| | HLA-DP beta-Chains | 5 | 2016 | 76 | 0.460 |
Why?
| | Protein Binding | 13 | 2020 | 1949 | 0.460 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 33 | 0.450 |
Why?
| | Animals | 28 | 2024 | 32737 | 0.440 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 17 | 0.430 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1500 | 0.420 |
Why?
| | Beryllium | 4 | 2016 | 148 | 0.420 |
Why?
| | Mice | 20 | 2022 | 15309 | 0.420 |
Why?
| | Arthropod Proteins | 1 | 2012 | 4 | 0.410 |
Why?
| | Salivary Proteins and Peptides | 1 | 2012 | 10 | 0.410 |
Why?
| | Aprotinin | 1 | 2012 | 9 | 0.410 |
Why?
| | Ticks | 1 | 2012 | 12 | 0.410 |
Why?
| | Metals | 1 | 2013 | 110 | 0.410 |
Why?
| | Ixodes | 1 | 2012 | 11 | 0.410 |
Why?
| | Crystallography, X-Ray | 11 | 2018 | 414 | 0.410 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 63 | 0.400 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2022 | 21 | 0.400 |
Why?
| | Evolution, Molecular | 2 | 2012 | 448 | 0.360 |
Why?
| | Alleles | 3 | 2010 | 816 | 0.350 |
Why?
| | Binding Sites | 6 | 2017 | 1206 | 0.340 |
Why?
| | Ferredoxins | 1 | 2007 | 3 | 0.300 |
Why?
| | Iron-Sulfur Proteins | 1 | 2007 | 26 | 0.300 |
Why?
| | Protein Structure, Tertiary | 8 | 2012 | 818 | 0.290 |
Why?
| | Oxidoreductases | 1 | 2007 | 93 | 0.280 |
Why?
| | Humans | 29 | 2023 | 117053 | 0.280 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2817 | 0.270 |
Why?
| | HIV Infections | 1 | 2020 | 2446 | 0.260 |
Why?
| | Antigens | 2 | 2020 | 319 | 0.250 |
Why?
| | Hybridomas | 3 | 2021 | 231 | 0.240 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 59 | 0.240 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1340 | 0.230 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 142 | 0.230 |
Why?
| | Molecular Conformation | 2 | 2022 | 135 | 0.230 |
Why?
| | Amino Acids | 2 | 2022 | 460 | 0.220 |
Why?
| | HLA-DR Serological Subtypes | 2 | 2013 | 4 | 0.220 |
Why?
| | Nucleic Acids | 1 | 2024 | 59 | 0.220 |
Why?
| | Oxygenases | 1 | 2002 | 10 | 0.220 |
Why?
| | Polychlorinated Biphenyls | 1 | 2002 | 9 | 0.220 |
Why?
| | Disulfides | 2 | 2022 | 90 | 0.220 |
Why?
| | Receptors, Steroid | 1 | 2023 | 54 | 0.220 |
Why?
| | Dioxygenases | 1 | 2002 | 26 | 0.220 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 33 | 0.210 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 9 | 0.210 |
Why?
| | Hepatitis B virus | 1 | 2022 | 25 | 0.210 |
Why?
| | AlkB Enzymes | 1 | 2022 | 1 | 0.210 |
Why?
| | Histones | 3 | 2018 | 544 | 0.210 |
Why?
| | Bacterial Proteins | 4 | 2018 | 756 | 0.210 |
Why?
| | Hirudo medicinalis | 1 | 2022 | 3 | 0.210 |
Why?
| | Leeches | 1 | 2022 | 3 | 0.210 |
Why?
| | Germ Cells | 1 | 2022 | 64 | 0.210 |
Why?
| | Rift Valley fever virus | 1 | 2021 | 2 | 0.210 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 47 | 0.210 |
Why?
| | Support Vector Machine | 1 | 2022 | 36 | 0.200 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 5 | 0.200 |
Why?
| | Transglutaminases | 1 | 2022 | 143 | 0.200 |
Why?
| | Protein Structure, Secondary | 3 | 2012 | 332 | 0.200 |
Why?
| | VDJ Exons | 1 | 2021 | 1 | 0.200 |
Why?
| | Glycoproteins | 2 | 2014 | 317 | 0.190 |
Why?
| | Environmental Pollutants | 1 | 2002 | 112 | 0.190 |
Why?
| | Early Growth Response Protein 2 | 1 | 2020 | 11 | 0.190 |
Why?
| | Sequence Alignment | 3 | 2012 | 333 | 0.190 |
Why?
| | GATA2 Transcription Factor | 1 | 2020 | 11 | 0.190 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 30 | 0.190 |
Why?
| | STAT5 Transcription Factor | 1 | 2020 | 43 | 0.190 |
Why?
| | HLA-DRB4 Chains | 1 | 2020 | 6 | 0.190 |
Why?
| | Mutation | 5 | 2020 | 3420 | 0.190 |
Why?
| | Muromegalovirus | 1 | 2020 | 13 | 0.190 |
Why?
| | Transcription Factor AP-1 | 1 | 2020 | 82 | 0.180 |
Why?
| | Response Elements | 1 | 2020 | 80 | 0.180 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 156 | 0.180 |
Why?
| | NFATC Transcription Factors | 1 | 2020 | 80 | 0.180 |
Why?
| | Toxoplasmosis | 1 | 2020 | 31 | 0.180 |
Why?
| | Toxoplasma | 1 | 2020 | 35 | 0.180 |
Why?
| | Interleukin-13 | 1 | 2020 | 134 | 0.180 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 199 | 0.180 |
Why?
| | Trace Elements | 1 | 2020 | 47 | 0.180 |
Why?
| | Mast Cells | 1 | 2020 | 116 | 0.180 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 224 | 0.170 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 85 | 0.170 |
Why?
| | Sarcoidosis | 1 | 2021 | 129 | 0.170 |
Why?
| | Major Histocompatibility Complex | 3 | 2013 | 219 | 0.170 |
Why?
| | Virus Latency | 1 | 2020 | 80 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 189 | 0.170 |
Why?
| | Herpesviridae Infections | 1 | 2020 | 139 | 0.170 |
Why?
| | Purines | 1 | 2020 | 161 | 0.160 |
Why?
| | Molecular Docking Simulation | 1 | 2019 | 101 | 0.160 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 21 | 0.160 |
Why?
| | Chronic Disease | 3 | 2020 | 1619 | 0.160 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2018 | 52 | 0.160 |
Why?
| | Antigen Presentation | 3 | 2020 | 194 | 0.160 |
Why?
| | Lysosomes | 1 | 2019 | 135 | 0.160 |
Why?
| | Protein Kinase C | 1 | 2020 | 283 | 0.160 |
Why?
| | Enzyme Inhibitors | 2 | 2017 | 775 | 0.160 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 741 | 0.150 |
Why?
| | Histone Demethylases | 1 | 2018 | 28 | 0.150 |
Why?
| | Thymus Gland | 1 | 2019 | 298 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 563 | 0.150 |
Why?
| | Protein Domains | 1 | 2019 | 212 | 0.150 |
Why?
| | Autoimmunity | 2 | 2014 | 829 | 0.150 |
Why?
| | Helminth Proteins | 1 | 2017 | 21 | 0.150 |
Why?
| | Glutaredoxins | 1 | 2017 | 12 | 0.150 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 57 | 0.150 |
Why?
| | Immune Tolerance | 1 | 2019 | 329 | 0.140 |
Why?
| | Insecta | 1 | 2017 | 69 | 0.140 |
Why?
| | Pyrimidines | 1 | 2020 | 379 | 0.140 |
Why?
| | Pancreas | 1 | 2019 | 278 | 0.140 |
Why?
| | Up-Regulation | 1 | 2020 | 837 | 0.140 |
Why?
| | Antiviral Agents | 1 | 2022 | 655 | 0.140 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1063 | 0.140 |
Why?
| | Kinetics | 3 | 2012 | 1583 | 0.140 |
Why?
| | Cysteine | 1 | 2017 | 175 | 0.140 |
Why?
| | Protein Folding | 1 | 2017 | 248 | 0.140 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 450 | 0.140 |
Why?
| | Catalytic Domain | 3 | 2021 | 205 | 0.130 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 2814 | 0.130 |
Why?
| | Chromogranin A | 1 | 2015 | 39 | 0.130 |
Why?
| | Genetic Predisposition to Disease | 3 | 2016 | 2227 | 0.130 |
Why?
| | Cancer Vaccines | 2 | 2021 | 138 | 0.130 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1327 | 0.120 |
Why?
| | Conserved Sequence | 2 | 2021 | 219 | 0.120 |
Why?
| | HIV-1 | 1 | 2020 | 771 | 0.120 |
Why?
| | DNA | 4 | 2024 | 1372 | 0.110 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2408 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1271 | 0.110 |
Why?
| | Phosphoproteins | 1 | 2014 | 299 | 0.110 |
Why?
| | Cross Reactions | 2 | 2011 | 116 | 0.100 |
Why?
| | Blood | 1 | 2012 | 96 | 0.100 |
Why?
| | Aged | 2 | 2022 | 19359 | 0.100 |
Why?
| | H-2 Antigens | 1 | 2011 | 111 | 0.100 |
Why?
| | Multigene Family | 1 | 2012 | 198 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1183 | 0.100 |
Why?
| | Ligands | 4 | 2020 | 565 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2021 | 1993 | 0.090 |
Why?
| | Lipids | 1 | 2014 | 584 | 0.090 |
Why?
| | Lysine | 1 | 2012 | 246 | 0.090 |
Why?
| | RNA | 2 | 2022 | 827 | 0.090 |
Why?
| | Oxidation-Reduction | 2 | 2018 | 910 | 0.090 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 60 | 0.090 |
Why?
| | Signal Transduction | 2 | 2020 | 4606 | 0.090 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 92 | 0.090 |
Why?
| | bcl-X Protein | 2 | 2006 | 41 | 0.090 |
Why?
| | bcl-2-Associated X Protein | 2 | 2006 | 46 | 0.090 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2021 | 138 | 0.090 |
Why?
| | Allergens | 1 | 2013 | 430 | 0.080 |
Why?
| | Membrane Proteins | 3 | 2006 | 1040 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2023 | 719 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 742 | 0.080 |
Why?
| | Glutamic Acid | 1 | 2010 | 215 | 0.080 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 114 | 0.080 |
Why?
| | Surface Plasmon Resonance | 1 | 2008 | 85 | 0.080 |
Why?
| | Spinacia oleracea | 1 | 2007 | 7 | 0.080 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 10 | 0.080 |
Why?
| | Synechocystis | 1 | 2007 | 5 | 0.080 |
Why?
| | Thioredoxins | 1 | 2007 | 30 | 0.070 |
Why?
| | Electron Transport | 1 | 2007 | 96 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2008 | 102 | 0.070 |
Why?
| | Cohort Studies | 1 | 2017 | 5051 | 0.070 |
Why?
| | Plant Proteins | 1 | 2007 | 81 | 0.070 |
Why?
| | Methylation | 3 | 2018 | 204 | 0.070 |
Why?
| | Burkholderia | 1 | 2006 | 13 | 0.070 |
Why?
| | Female | 4 | 2021 | 60635 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2012 | 590 | 0.070 |
Why?
| | Hydrolases | 1 | 2006 | 52 | 0.070 |
Why?
| | Structure-Activity Relationship | 1 | 2007 | 516 | 0.070 |
Why?
| | Phenols | 1 | 2006 | 85 | 0.070 |
Why?
| | Iron | 1 | 2007 | 242 | 0.070 |
Why?
| | Complementarity Determining Regions | 3 | 2011 | 45 | 0.060 |
Why?
| | Demethylation | 1 | 2024 | 3 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2007 | 1258 | 0.060 |
Why?
| | Meiosis | 1 | 2024 | 61 | 0.060 |
Why?
| | Lung Diseases | 1 | 2010 | 693 | 0.060 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 80 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2003 | 145 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2002 | 36 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 201 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 216 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 646 | 0.050 |
Why?
| | Catalysis | 1 | 2002 | 281 | 0.050 |
Why?
| | Mammals | 1 | 2024 | 254 | 0.050 |
Why?
| | Chemical Phenomena | 1 | 2021 | 82 | 0.050 |
Why?
| | Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| | Antigens, Fungal | 1 | 2021 | 26 | 0.050 |
Why?
| | Spodoptera | 1 | 2021 | 37 | 0.050 |
Why?
| | Interferon Type I | 1 | 2022 | 130 | 0.050 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 77 | 0.050 |
Why?
| | Interleukin-2 | 2 | 2015 | 419 | 0.050 |
Why?
| | Middle Aged | 2 | 2021 | 27173 | 0.050 |
Why?
| | Base Sequence | 2 | 2015 | 2123 | 0.050 |
Why?
| | Models, Chemical | 1 | 2002 | 261 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2023 | 340 | 0.050 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 145 | 0.050 |
Why?
| | Fungal Proteins | 1 | 2021 | 126 | 0.050 |
Why?
| | Transcription Factors | 2 | 2006 | 1557 | 0.050 |
Why?
| | Antigens, Protozoan | 1 | 2020 | 19 | 0.050 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2020 | 41 | 0.050 |
Why?
| | Caenorhabditis elegans | 1 | 2024 | 286 | 0.050 |
Why?
| | Disease Resistance | 1 | 2020 | 28 | 0.050 |
Why?
| | Crystallization | 2 | 2015 | 142 | 0.050 |
Why?
| | Immediate-Early Proteins | 1 | 2020 | 52 | 0.050 |
Why?
| | Escherichia coli Proteins | 1 | 2022 | 170 | 0.050 |
Why?
| | DNA Repair | 1 | 2022 | 197 | 0.040 |
Why?
| | Protozoan Proteins | 1 | 2020 | 63 | 0.040 |
Why?
| | Antibody Affinity | 1 | 2020 | 52 | 0.040 |
Why?
| | Adult | 2 | 2021 | 31003 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2003 | 393 | 0.040 |
Why?
| | Antibody Specificity | 1 | 2020 | 179 | 0.040 |
Why?
| | Cell Line | 2 | 2020 | 2670 | 0.040 |
Why?
| | Genome | 1 | 2022 | 269 | 0.040 |
Why?
| | Viral Proteins | 1 | 2021 | 287 | 0.040 |
Why?
| | Flow Cytometry | 2 | 2015 | 1063 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2018 | 4 | 0.040 |
Why?
| | Cells, Cultured | 2 | 2020 | 3956 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 47 | 0.040 |
Why?
| | Salmonella | 1 | 2018 | 54 | 0.040 |
Why?
| | Genes, Bacterial | 1 | 2018 | 159 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1136 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 352 | 0.040 |
Why?
| | Protein Denaturation | 1 | 2017 | 73 | 0.040 |
Why?
| | RNA, Bacterial | 1 | 2018 | 176 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 546 | 0.040 |
Why?
| | Proteolysis | 1 | 2018 | 147 | 0.040 |
Why?
| | Proline | 1 | 2017 | 70 | 0.040 |
Why?
| | Apoptosis | 1 | 2006 | 2433 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2021 | 786 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 296 | 0.040 |
Why?
| | Genomics | 1 | 2022 | 658 | 0.040 |
Why?
| | Enzyme Activation | 1 | 2018 | 793 | 0.040 |
Why?
| | Arginine | 1 | 2018 | 240 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 4839 | 0.030 |
Why?
| | Substrate Specificity | 2 | 2010 | 362 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 930 | 0.030 |
Why?
| | Baculoviridae | 1 | 2015 | 45 | 0.030 |
Why?
| | Male | 2 | 2021 | 56665 | 0.030 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2006 | 38 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2006 | 188 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3099 | 0.030 |
Why?
| | Sodium | 1 | 2014 | 198 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 525 | 0.030 |
Why?
| | Lung | 2 | 2016 | 3588 | 0.030 |
Why?
| | Oxidative Stress | 1 | 2018 | 1148 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2014 | 626 | 0.030 |
Why?
| | HLA Antigens | 1 | 2013 | 220 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 2 | 2006 | 615 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2011 | 49 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 45 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 33 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 75 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 201 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 2010 | 125 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 114 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 634 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2009 | 132 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 373 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 6 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 356 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 668 | 0.020 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2006 | 15 | 0.020 |
Why?
| | Enterotoxins | 1 | 2006 | 86 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 160 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2010 | 491 | 0.020 |
Why?
| | Immunotherapy | 1 | 2010 | 491 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 86 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 107 | 0.020 |
Why?
| | Point Mutation | 1 | 2006 | 225 | 0.020 |
Why?
| | Transfection | 1 | 2006 | 877 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2011 | 2236 | 0.010 |
Why?
| | B-Cell Activating Factor | 1 | 2003 | 18 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 66 | 0.010 |
Why?
| | Solubility | 1 | 2003 | 232 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 180 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2003 | 311 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 362 | 0.010 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 288 | 0.010 |
Why?
| | Computer Simulation | 1 | 2003 | 903 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 2003 | 591 | 0.010 |
Why?
|
|
Dai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|